mesalamine has been researched along with Acquired Nephrogenic Diabetes Insipidus in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Martín, F | 1 |
| Sánchez Heras, M | 1 |
| Sánchez Martínez, L | 1 |
| Rodríguez-Zapata, M | 1 |
1 other study available for mesalamine and Acquired Nephrogenic Diabetes Insipidus
| Article | Year |
|---|---|
[Nephrogenic diabetes insipidus secondary to chronic interstitial nephritis associated with mesalazine therapy].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Diabetes Insipidus, Nephrogenic; Di | 2002 |